Your browser doesn't support javascript.
loading
Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study.
Wen, Chenlei; Zhang, Lei; Yang, Ying; Jin, Yangbing; Ren, Dandan; Zhang, Zehui; Zou, Siyi; Li, Fanlu; Sun, Huaibo; Jin, Jiabin; Lu, Xiongxiong; Xie, Junjie; Cheng, Dongfeng; Xu, Zhiwei; Chen, Huan; Mao, Beibei; Zhang, Jun; Wang, Jiancheng; Deng, Xiaxing; Peng, Chenghong; Li, Hongwei; Jiang, Cen; Lin, Lin; Zhang, Henghui; Chen, Hao; Shen, Baiyong; Zhan, Qian.
Affiliation
  • Wen C; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Zhang L; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Yang Y; Genecast Biotechnology Co. Ltd, Wuxi, Jiangsu Province.
  • Jin Y; Genecast Biotechnology Co. Ltd, Wuxi, Jiangsu Province.
  • Ren D; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Zhang Z; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Zou S; Genecast Biotechnology Co. Ltd, Wuxi, Jiangsu Province.
  • Li F; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Sun H; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Jin J; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Lu X; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Xie J; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Cheng D; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Xu Z; Genecast Biotechnology Co. Ltd, Wuxi, Jiangsu Province.
  • Chen H; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Mao B; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Zhang J; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Wang J; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Deng X; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Peng C; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Li H; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Jiang C; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Lin L; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
  • Zhang H; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai.
  • Chen H; Genecast Biotechnology Co. Ltd, Wuxi, Jiangsu Province.
  • Shen B; Genecast Biotechnology Co. Ltd, Wuxi, Jiangsu Province.
  • Zhan Q; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
Int J Surg ; 109(7): 1941-1952, 2023 Jul 01.
Article in En | MEDLINE | ID: mdl-37026827

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Surg Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Surg Year: 2023 Document type: Article